The global brachytherapy market is estimated to grow at a CAGR of 3.5% during the forecast period. Brachytherapy has evolved over the decades owing to a significant transformation in the way that brachytherapy is applied for different treatment locations. This is resulting owing to the development of new treatment delivery techniques and technologically advanced computer planning systems. Advanced 3D imaging modalities have been integrated into treatment planning methods that allow full 3D dose distributions to be computed. The techniques of treatment that involves online planning have increased that supports dose distributions to be updated and calculated in real-time according to the actual clinical situation. For instance, in the treatment of early-stage breast cancer, electronic brachytherapy treatment methods are being utilized in which the radiation dose is delivered in the procedure.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/brachytherapy-market
There have been considerable advances in the treatment applicator design that enables the application of advanced 3D imaging techniques for planning. As a result, the manufacturers have started the implementation of new dose calculation algorithms that will correct for applicator shielding and tissue inhomogeneities. Earlier, brachytherapy dose was prescribed with the use of 2D planning based on radiographs. However, a transition has made to 3D image-guided adaptive brachytherapy that facilitates the evaluation of tumor regression during confirmation and radiotherapy of the radiation dose to the residual tumor in an adaptive, individualized technique. Acquiring a 3D data set with the use of magnetic resonance imaging (MRI) or computed tomography (CT) has led to more precise planning and superior dose determination to volumes of both the tumor and the organs at risk (OARs).
Modulated arc therapy and intensity-modulated radiotherapy have emerged the way external beam radiotherapy (EBRT) is planned and delivered and as a result, 3D-image-guided and planning techniques have further emerged the area of brachytherapy. Therefore, these advances in brachytherapy are contributing to the increase in the safety and accuracy of the treatment, which in turn, is driving the global brachytherapy market. C4 Imaging is offering low-dose and high-dose-rate (HDR) brachytherapy based on MRI that uses positive contrast MRI markers that supports to minimize the uncertainties rising from CT-MRI fusion that minimizes the requirement for post-implant multimodality imaging. The Sirius MRI Marker is visible with MRI that certainly detecting the location of radioactive sources. It is composed of a sealed biocompatible, polymer capsule which consists of C4, a unique MRI agent. The length of each capsule is 5.5 mm and the diameter is 0.8 mm.
The better imaging quality of MRI can support to increase the precision of brachytherapy and shows the actual association of radiation dose to targeted cancer and nearby critical dose-limiting anatomy. Furthermore, in September 2019, the company introduced Orion HDR Marker to create a precise, positive MRI signal and facilitates greater anatomical imaging properties of MRI which is useful while planning treatment. As the HDR is gaining significant importance owing to its convenience and effectiveness, the MRI usage can deliver more anatomical detail rather than CT. This, in turn, will likely boost the market share of the company and thereby will promote the growth of the global brachytherapy market.
Global Brachytherapy Market Segmentation
By Application
- Breast Cancer
- Gynecological Cancer
- Prostate Cancer
- Skin Cancer
- Brain Cancer
- Others (Rectal Cancer and Head and Neck Cancer)
By Type
- Low-Dose Rate (LDR)
- High-Dose Rate (HDR)
A full report of Brachytherapy Market is available at: https://www.omrglobal.com/industry-reports/brachytherapy-market
Global Brachytherapy Market – Segment by Region
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- AngioDynamics, Inc.
- Best Medical International, Inc.
- Boston Scientific Corp.
- R. Bard, Inc. (Becton, Dickinson & Co.)
- C4 Imaging, LLC
- Carl Zeiss Meditec AG
- CIVCO Medical Solutions
- Eckert & Ziegler BEBIG
- Elekta AB
- General Electric Co.
- Hologic, Inc.
- iCAD, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
